ZetrOZ
ZetrOZ develops and manufactures non-invasive medical devices, including the FDA-cleared sam® series, to accelerate tissue healing and manage pain for musculoskeletal conditions.
Company Overview
ZetrOZ develops and manufactures non-invasive medical devices aimed at accelerating tissue healing and relieving pain in individuals with chronic musculoskeletal conditions. With its headquarters in Trumbull, CT, the company maintains four manufacturing facilities across the United States. ZetrOZ is recognized for its innovative approach in sports medicine and is acknowledged as a top innovator in the field by Medtech Strategist.
Products
ZetrOZ offers a range of wearable medical devices including the FDA-cleared multi-hour ultrasound device known as sam®. The product lineup features sam® Sport, introduced in 2013 as the first and only FDA-cleared device for continuous multi-hour ultrasound therapy; sam® Pro 2.0, the only long duration low intensity ultrasound device cleared for daily home use by the FDA; and sam® X1, a wireless ultrasound device designed for at-home use for pain management and soft tissue repair.
Patents
ZetrOZ holds over 46 patents related to non-invasive soft tissue healing and pain management technology. These patents underline the company's commitment to advancing medical innovation and providing effective solutions for managing chronic musculoskeletal conditions.
Partnerships
ZetrOZ has established significant partnerships with major sports organizations such as USA Field Hockey and the National Basketball Trainer’s Association. Additionally, the company collaborates with prominent institutions including the National Institute of Aging, part of the National Institutes of Health, and the Orthopedic Foundation. These partnerships enhance ZetrOZ's influence and credibility in the field of sports medicine and medical technology.